+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

A novel somatostatin analogue prevents renal diabetic complications in the non obese diabetic -mouse



A novel somatostatin analogue prevents renal diabetic complications in the non obese diabetic -mouse



Diabetologia 43(Supplement 1): A37




(PDF emailed within 1 workday: $29.90)

Accession: 034312209

Download citation: RISBibTeXText


Related references

A novel somatostatin analogue prevents early renal complications in the nonobese diabetic mouse. Kidney International 60(2): 505-512, 2001

Effects of somatostatin analogue on renal complications and IGF-I levels in the neonatal STZ-diabetic rats. Growth Hormone & IGF Research 9(5): 385, 1999

Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 32(4): 261-265, 1989

Metabolic Disorders and Diabetic Complications in Spontaneously Diabetic Torii Lepr (fa) Rat: A New Obese Type 2 Diabetic Model. Journal of Diabetes Research 2013: 948257-948257, 2013

Pancreatic somatostatin contents in spontaneously diabetic KK and non-obese diabetic (NOD) mice. Hormone and Metabolic Research 14(6): 292-298, 1982

Effect of the somatostatin analogue octreotide on renal function in conscious diabetic rats. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 635A, 2000

Effects of the somatostatin analogue octreotide on renal function in conscious diabetic rats. Nephrology, Dialysis, Transplantation 16(10): 2002-2007, 2001

RFLP analysis of the MHC class III region defines unique haplotypes for the non-obese diabetic, cataract Shionogi and the non-obese non-diabetic mouse strains. Diabetologia 36(8): 727-733, 1993

The dose dependent effects of somatostatin analogue in diabetic rats Dissociation between GFR and renal growth. Journal of the American Society of Nephrology 3(3): 764, 1992

Long-term effects of a somatostatin analogue on renal haemodynamics and hypertrophy in diabetic rats. Clinical Science 83(5): 575-581, 1992

Effect of a somatostatin analogue (SMS 201-995) on renal function and urinary protein excretion in diabetic rats. Journal of Diabetic Complications 5(2-3): 181-183, 1991

Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse. Plos One 13(5): E0196598, 2018

Effect of long-term administration of somatostatin analogue on renal enlargement in uninephrectomized-diabetic rats. Journal of Korean Medical Science 8(2): 127-134, 1993

Renal response to a somatostatin analogue sms 201 995 in type 1 insulin dependent diabetic patients without overt nephropathy. Diabetologia 31(7): 532A, 1988

Troglitazone prevents insulin dependent diabetes in the non-obese diabetic mouse. European Journal of Pharmacology 357(2-3): 221-225, Sept 18, 1998